最後更新 2024-12-22 16:57:05 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

510.5%


截至2024-09-30

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

摩德納公司(Moderna, Inc.)是一家生物技術公司,在美國、歐洲和國際上發現、開發和商業化信使RNA治療和疫苗,用於治療傳染病、腫瘤免疫學、罕見疾病、心血管疾病和自身免疫疾病。其呼吸道疫苗包括COVID-19、流感、呼吸道合胞病毒、常見冠狀病毒和hMPV+PIV3疫苗;潛伏疫苗包括巨細胞病毒、EB病毒、人類免疫缺陷病毒、單純疱疹病毒和水痘-帶狀疱疹病毒疫苗;公共衛生疫苗包括寨卡和尼帕病毒疫苗。該公司還提供全身分泌和細胞表面治療;癌症疫苗,如個性化癌症、KRAS和檢查點疫苗;腫瘤內免疫腫瘤產品;局部再生、全身細胞內和吸入性肺部治療。它與AstraZeneca PLC、Merck & Co., Inc.、Vertex Pharmaceuticals Incorporated、Vertex Pharmaceuticals (Europe) Limited、Carisma Therapeutics, Inc.、Metagenomi, Inc.、國防高級研究計劃局、生物醫學高級研究和開發局、改變生命研究所和比爾及梅琳達·蓋茨基金會有戰略聯盟,並與Chiesi Farmaceutici S.P.A.有合作和許可協議。該公司曾名為Moderna Therapeutics, Inc.,於2018年8月更名為Moderna, Inc.。該公司成立於2010年,總部位於麻薩諸塞州劍橋。



Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Biotechnology

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning